Julian S Gangolli's Net Worth
$16.1 Million
Who is Julian S Gangolli?
Julian S Gangolli has an estimated net worth of $16.1 Million. This is based on reported shares across multiple companies, which include GW PHARMACEUTICALS PLC, Revance Therapeutics, Inc., Krystal Biotech, Inc., Outlook Therapeutics, Inc., and ALLERGAN INC.
SEC CIK
Julian S Gangolli's CIK is 0001532023
Past Insider Trading and Trends
2012 was Julian S Gangolli's most active year for acquiring shares with 7 total transactions. Julian S Gangolli's most active month to acquire stocks was the month of April. 2019 was Julian S Gangolli's most active year for disposing of shares, totalling 17 transactions. Julian S Gangolli's most active month to dispose stocks was the month of February. 2014 saw Julian S Gangolli paying a total of $5,093,976.03 for 43,849 shares, this is the most they've acquired in one year. In 2012 Julian S Gangolli cashed out on 180,855 shares for a total of $8,316,023.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GW PHARMACEUTICALS PLC No price found
President, North America
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.55 | -$8,456,044.40 | 106.55K |
Scheduled
|
May 10
| ||
Form 4
| +5.19% | 5.26K |
$12.45 | -$74,681.53 | 106.55K |
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revance Therapeutics, Inc. (RVNC) Snapshot price: $5.365
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.30% | 3.53K |
—
|
—
| 30.11K |
May 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +29.54% | 6.06K |
—
|
—
| 26.57K |
May 4
| |||
Form 4
| +24.32% | 4.01K |
—
|
—
| 20.51K |
May 5
| |||
Form 4
| +57.14% | 6K |
—
|
—
| 16.5K |
May 14
| |||
Form 4
| +75.00% | 4.5K |
—
|
—
| 10.5K |
May 9
| |||
Form 4
| +100.00% | 3K |
—
|
—
| 6K |
May 10
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Krystal Biotech, Inc. (KRYS) Snapshot price: $112
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Outlook Therapeutics, Inc. (OTLK) Snapshot price: $0.4215
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALLERGAN INC No price found
CVP & Pres, North America
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.71K |
—
|
—
| 0.3 |
Mar 6 - Mar 17
| |||
Form 4
| +12.86% | 245 |
$234.00 | -$62,946.00 | 2.15K |
Feb 20
| |||
Form 4
| -37.65% | -1.15K |
$230.15 | -$264,672.50 | 1.9K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
| 23.11K |
Mar 6
| |||
Form 4
| -23.35% | -1.88K |
$125.07 | -$235,131.60 | 6.17K |
Feb 21
| |||
Form 4
|
—
|
0
|
$81.88 | -$2,957,775.00 | 8.05K |
Scheduled
|
Dec 27
| ||
Form 4
|
—
|
0
|
—
|
—
| 24.91K |
Feb 28
| |||
Form 4
| -17.95% | -2.70K |
$108.08 | -$291,707.92 | 12.34K |
Feb 20 - Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
| 27.6K |
Jan 11
| |||
Form 4
| -1.13% | -353.00 |
$91.73 | -$32,380.69 | 31.01K |
Dec 31
| |||
Form 4
|
—
|
0
|
$72.16 | -$3,552,141.23 | 15.78K |
Nov 27 - Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
| 27.93K |
Mar 15
| |||
Form 4
| -0.97% | -157.00 |
$87.27 | -$13,701.39 | 16.1K |
Feb 22
| |||
Form 4
| +2.03% | 323 |
—
|
—
| 16.26K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
| 27.75K |
Nov 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||